Tuesday, March 04, 2025 | 01:10 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

AstraZeneca, Russia's Sputnik V developer to sign cooperation memorandum

President Vladimir Putin hailed British drugmaker AstraZeneca's decision to test combining its own experimental Covid-19 vaccine with Russia's Sputnik V shot

AstraZeneca
Premium

Clinical trials, still under way, have shown Sputnik has an efficacy of over 90 per cent

Reuters
Britain’s AstraZeneca and Russia's Gamaleya Institute, which developed the Sputnik V vaccine, will sign a memorandum of intent on cooperation on Monday, the Kremlin said.
 
Russia’s RDIF sovereign wealth fund said this month AstraZeneca would start clinical trials to test a combination of its experimental Covid-19 vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker's vaccine.
 
President Vladimir Putin hailed British drugmaker AstraZeneca's decision to test combining its own experimental Covid-19 vaccine with Russia's Sputnik V shot.
 
Clinical trials, still under way, have shown Sputnik has an efficacy

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in